In vivo studies revealed that intratumoral administration of YME1L-shRNA-expressing adeno-associated virus (AAV) curtailed subcutaneous NPC xenograft growth in nude mice. The gene discussed is YME1L1; the disease is nasopharyngeal carcinoma.